Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-035269
Filing Date
2013-07-03
Accepted
2013-07-03 10:40:47
Documents
1
Period of Report
2013-06-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3164
  Complete submission text file 0001209191-13-035269.txt   4522
Mailing Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850
Business Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850 240-268-2000
NOVAVAX INC (Issuer) CIK: 0001000694 (see all company filings)

EIN.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CANCER VAX CORP 2110 RUTHERFORD ROAD CARLSBAD CA 92008
Business Address
PHILLIPS BARCLAY A (Reporting) CIK: 0001265801 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26770 | Film No.: 13951438